Erythromycin, ampicillin, alkalization and increased diuresis in treatment of human L-phase urinary tract infections.
D000136:Acid-Base Equilibrium; D000667:Ampicillin / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D004231:Diuresis; D004917:Erythromycin / Q000627:therapeutic use*; D004926:Escherichia coli; D005260:Female; D006801:Humans; D007223:Infant; D007740:L Forms / Q000187:drug effects*; D008297:Male; D009582:Nitrofurantoin / Q000627:therapeutic use; D009994:Osmolar Concentration; D011513:Proteus mirabilis; D012008:Recurrence; D013291:Streptococcus; D013449:Sulfonamides / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology
D001639:Bicarbonates; D013449:Sulfonamides; D004917:Erythromycin; D000667:Ampicillin; D009582:Nitrofurantoin